CMA is proud to share our Regulatory Outcomes Report 2025—a detailed summary of the regulatory advocacy, engagement, and outcomes we’ve delivered on behalf of our members over the past 18 months.

This report highlights CMA’s role in supporting a strong, sustainable complementary medicines industry—championing proportionate, risk-based regulation and ensuring that innovation, product access and industry growth remain possible in a highly regulated environment.

You can view or download the full report below.